Smith+Nephew introduces the RENASYS™ EDGE Negative Pressure Wound Therapy System – an exciting new option in home-based care for patients living with chronic wounds
01 avr. 2024 08h00 HE
|
Smith & Nephew UK Ltd
Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, is pleased to announce the launch of its RENASYS EDGE Negative Pressure Wound Therapy (NPWT) System in the US as a...
Wound Healing Technology Company Merakris Adds Two Executives to Leadership Team
15 août 2023 06h30 HE
|
Merakris Therapeutics
RESEARCH TRIANGLE PARK, N.C., Aug. 15, 2023 (GLOBE NEWSWIRE) -- Merakris Therapeutics has added two new executives to its leadership team as it prepares to expand its product line and increase its...
Wound Care Market revenue to cross USD 58 Billion by 2035, says Research Nester
01 août 2023 07h00 HE
|
Research Nester
New York, Aug. 01, 2023 (GLOBE NEWSWIRE) -- The global wound care market size is slated to expand at ~8.4% CAGR between 2023 and 2035. The market is poised to garner a revenue of USD 58 billion by...
Anti-Biofilm Wound Dressing Market Size & Share to Surpass $1315.59 Billion by 2030 | Vantage Market Research
04 mai 2023 06h48 HE
|
Vantage Market Research
WASHINGTON, May 04, 2023 (GLOBE NEWSWIRE) -- Global Anti-Biofilm Wound Dressing Market is valued at USD 710.5 Million in 2022 and is projected to reach a value of USD 1315.59 Million by 2030 at a...
Arch Therapeutics’ AC5® Advanced Wound System Receives Dedicated HCPCS Billing Code from The Centers for Medicare & Medicaid Services
09 mars 2023 07h50 HE
|
Arch Therapeutics, Inc.
FRAMINGHAM, Mass., March 09, 2023 (GLOBE NEWSWIRE) -- Arch Therapeutics, Inc. (OTCQB: ARTH) (“Arch” or the “Company”), a marketer and developer of novel self-assembling wound care and biosurgical...
Arch Therapeutics Announces Addition of Contract Sales Force to Advance Commercialization of AC5® Advanced Wound System in Government Facilities
07 mars 2023 07h50 HE
|
Arch Therapeutics, Inc.
FRAMINGHAM, Mass., March 07, 2023 (GLOBE NEWSWIRE) -- Arch Therapeutics, Inc. (OTCQB: ARTH) (“Arch” or the “Company”), a marketer and developer of novel self-assembling wound care and biosurgical...
Combined Sales of Anti-biofilm Wound Dressing Market is expected to reach US$ 1939.45 million by 2033; Development in Telehealth Platforms Surges the Sales of Anti-biofilm Wound Dressing | Future Market Insights, Inc.
23 janv. 2023 12h30 HE
|
Future Market Insights Global and Consulting Pvt. Ltd.
NEWARK, Del, Jan. 23, 2023 (GLOBE NEWSWIRE) -- The net worth of the market share of the anti-biofilm wound dressing is predicted to reach from US$ 782.60 million in 2023 to over US$ 1939.45...
Arch Therapeutics Announces Formation of Medical Advisory Board to Advance Commercialization of AC5® Advanced Wound System
18 janv. 2023 07h35 HE
|
Arch Therapeutics, Inc.
FRAMINGHAM, Mass., Jan. 18, 2023 (GLOBE NEWSWIRE) -- Arch Therapeutics, Inc. (OTCQB: ARTH) (“Arch” or the “Company”), a marketer and developer of novel self-assembling wound care and biosurgical...
Merakris Announces Review in Biomedicines Medical Journal Highlighting Therapeutic Potential of Cell-Free Amniotic Fluid
29 nov. 2022 06h15 HE
|
Merakris Therapeutics
RESEARCH TRIANGLE PARK, N.C., Nov. 29, 2022 (GLOBE NEWSWIRE) -- A review published recently in the international scientific journal Biomedicines highlights the therapeutic benefits of amniotic fluid...
Key Opinion Leaders Presented Arch Therapeutics’ AC5® Advanced Wound System at 2022 Symposium on Advanced Wound Care (SAWC) Fall
18 oct. 2022 06h50 HE
|
Arch Therapeutics, Inc.
FRAMINGHAM, Mass., Oct. 18, 2022 (GLOBE NEWSWIRE) -- Arch Therapeutics, Inc. (OTCQB: ARTH) (“Arch” or the “Company”), a marketer and developer of novel self-assembling wound care and biosurgical...